Metabolically healthy obesity

Metabolically healthy obesity
Synonyms	MHO, Metabolically-healthy obesity
Pronounce	N/A
Specialty	N/A
Symptoms	Obesity without metabolic abnormalities
Complications	Potential long-term cardiovascular risks
Onset	Variable, typically adulthood
Duration	Chronic, variable
Types
Causes	Genetic, environmental, lifestyle factors
Risks	Family history, diet, physical activity levels
Diagnosis	Clinical assessment, absence of metabolic syndrome components
Differential diagnosis	Metabolic syndrome, standard obesity
Prevention	Healthy lifestyle, balanced diet, regular exercise
Treatment	Lifestyle modifications (diet and physical activity)
Medication	Generally not required, supportive if metabolic health deteriorates
Prognosis	Controversial; some studies suggest potential long-term risks
Frequency	Estimates vary widely, 6–75%
Deaths	Usually related to eventual metabolic complications

Metabolically healthy obesity (MHO), also known as metabolically-healthy obesity, is a disputed medical condition characterized by obesity that does not result in metabolic complications commonly associated with excess weight. These complications include dyslipidemia, impaired glucose tolerance, and metabolic syndrome.

Characteristics

There is no universally accepted definition for MHO. However, diagnostic criteria generally include:

• Obesity as defined by a body mass index (BMI) of ≥30 kg/m²
• Absence of significant metabolic abnormalities such as:
  • Normal blood lipid levels
  • Normal glucose tolerance
  • Absence of insulin resistance

Individuals with MHO typically demonstrate:

• Lower levels of visceral adipose tissue
• Smaller adipocytes (fat cells)
• A reduced inflammatory profile compared to metabolically unhealthy obese individuals

Due to these characteristics, it has been proposed that cardiometabolic risk might not significantly improve following weight loss interventions in MHO individuals.

Epidemiology

Estimates of the prevalence of MHO vary widely, ranging from 6% to 75%. It is generally believed that approximately 10–25% of obese individuals may be metabolically healthy. Reported findings include:

• One study identifying 47.9% of obese individuals as having MHO
• Another reporting just 11%

MHO is more commonly observed in women than in men and tends to decline with increasing age.

Clinical Significance

The clinical importance of MHO remains controversial. While MHO individuals appear to have a more favorable metabolic profile in the short term, long-term studies suggest they may still be at elevated risk for:

• Cardiovascular disease
• Type 2 diabetes mellitus
• Other obesity-related complications

Therefore, continued monitoring and lifestyle optimization are recommended.

Management

Even in the absence of metabolic dysfunction, management for individuals with MHO typically includes:

• Balanced, nutrient-rich diet
• Regular physical activity
• Weight monitoring and regular check-ups to detect any metabolic changes early

Current guidelines emphasize the importance of preventive care and individualized risk assessment for patients with MHO.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia